Dr. Rashmi Dalvi

• Dr. L.M. Sanghvi Award – Best Oral Presentation, Bombay
• Best Subspecialty Chapter Award – Indian Academy of Pediatrics (IAP)
• SIOP Award for Best Paper – International Training Project, Portugal (Co-recipient)
• Felicitated at national forums for excellence in Paediatric Hematology
• Recognized for contributions to Paediatric Oncology education, research, and mentorship
• Delivered multiple keynote addresses at leading Paediatric Hematology-Oncology conferences

• Authored multiple papers in paediatric blood disorders and oncology
• Contributor to national paediatric treatment protocols and child health guidelines
• Researcher in immune and genetic conditions in children For example-

Major A, Palese M, Ermis E, James A, Villarroel M, Klussmann FA, Hessissen L, Geel J, Khan MS, Dalvi R, Sullivan M, Kearns P, Frazier AL, Pritchard-Jones K, Nakagawara A, Rodriguez-Galindo C, Volchenboum SL. Mapping Pediatric Oncology Clinical Trial Collaborative Groups on the Global Stage. JCO Glob Oncol. 2022 Feb;8:e2100266. doi: 10.1200/GO.21.00266. PMID: 35157510; PMCID: PMC8853619. Li CK, Dalvi R, Yonemori K, Ariffin H, Lyu CJ, Farid M, Gonzales-Santos JRN, Zhou Q, Bielack S, Brugieres L, Blondeel A, Essiaf S, Peccatori FA, Jezdic S, Stark DP, Douillard JY, Saloustros E, Mountzios G. Care of adolescents and young adults with cancer in Asia: results of an ESMO/SIOPE/SIOP Asia survey. ESMO Open. 2019 Jun 6;4(3):e000467. doi: 10.1136/esmoopen-2018-000467. PMID: 31231565; PMCID: PMC6555609.

“Children aren’t just little adults—they deserve tailored, empathetic, and accurate care. That’s what I strive to provide each day.” – Dr. Rashmi Dalvi

• Successfully managed complex bone marrow failure in children with rare genetic syndromes
• Lifesaving treatment delivered to infants with immune deficiency through early diagnosis and specialized care
• Empowered families through education and long-term support in paediatric cancer cases

“Dr. Dalvi is not just a doctor—she is a guardian angel for our son. Her clear explanations and kind nature helped us through the toughest phase of our lives.” – Mrs. R. Deshmukh, Mumbai “She saved my daughter’s life from a rare bleeding disorder. We owe everything to her precision and patience.” – Mr. A. Mehta, Pune “Even after treatment, Dr. Rashmi keeps in touch with us and always checks on my child’s progress. She truly cares.” – Mrs. Lata Jain, Surat “We were overwhelmed with medical terms, but Dr. Rashmi broke everything down simply. Her warmth brought us hope.” – Mohammed Farhan, Malegaon

Dr. Dalvi is an active member and thought leader in several esteemed national and international medical organizations:

• Mumbai Haematology Group (MHG)
• Indian Society of Hematology and Transfusion Medicine (ISHTM)
• Indian Society of Medical and Pediatric Oncology (ISMPO)
• International Society of Paediatric Oncology (SIOP)

Regular contributor to conferences, research collaborations, and policy development in Pediatric Hematology-Oncology

• Continental President, SIOP-Asia (2018–2021) – Global leadership in pediatric oncology
• Professor & Head, Pediatrics & Pediatric Hematology-Oncology, Bombay Hospital Institute of Medical Sciences
• Visiting Consultant,
  • NH-SRCC Children’s Hospital, Mumbai
  • Pediatric Hematology Oncology – BMT Department, LTMG Medical College Hospita

•  Alumnus of Seth G.S. Medical College / KEM Hospital, Mumbai
• Specialized training in Pediatric Hematology-Oncology (PHO)
  • India (1988)
  • Children’s Hospitals of Michigan (1996)
  • Philadelphia (UICC-ICRETT Fellowship, 2001)

• Among the pioneers in Pediatric Hematology-Oncology in India
• Over 30 years of clinical and academic experience in PHO & Pediatric Immunology
• Former Faculty at B.J. Wadia Hospital for Children
• Numerous research publications, national & international conference presentations
•  Clinical focus:
  • Lymphomas
  • Histiocytic Disorders & HLH
  • Pediatric Nutrition & Supportive Care
  • Cancer Registries & Early Diagnosis

• Active member, SIOP & SIOP-PODC Committee since 1992
• 🇮🇳 Founder, SIOP-India Project: “NTP-PPO” (Early Diagnosis & Treatment Abandonment in Childhood Cancer)
• Held leadership roles in:
  • National PHO Society, India (Chair, 2009–2012)
  • SIOP-PODC Education & Training Committee (Chair, 2010–2013)
  • SIOP Asia 2020–21 Conference, Mumbai (Chair, Local Organizing Committee)
  • SIOP-PARC Steering Committee (Member)
  • SIOP Membership Committee (Vice-Chair)
  • Asian Pediatric Hematology Oncology Group (APHOG) – Founder Member & Executive Council Member
  • ICON Ethics Committee and Stem Cell Committee, KEM Hospital

Dr. Rashmi Dalvi is a strong proponent of integrating cutting-edge medical technologies and innovative treatment approaches in pediatric care. Her work reflects a forward-thinking mindset that combines evidence-based practice with the latest advancements in the field. Pioneering Clinical Research

• Actively involved in clinical trials and research studies exploring novel therapies for:
  • Pediatric Leukemia – including targeted therapies, molecular diagnostics, and minimal residual disease (MRD) monitoring
  • Hemophilia – participating in trials on extended half-life factor concentrates, gene therapy, and non-factor therapies such as emicizumab
• Collaborates with national and international research groups to improve treatment outcomes and promote evidence-based pediatric hematology-oncology

Multidisciplinary, Patient-Centered Approach

• Strong advocate for comprehensive, multidisciplinary care models for children with:
  • Chronic illnesses, such as thalassemia, immunodeficiency disorders, and pediatric cancers
  • Involvement of hematologists, oncologists, nutritionists, psychologists, social workers, and rehabilitation specialists to ensure holistic care
• Focus on personalized treatment plans, family counseling, and long-term follow-up to enhance quality of life and treatment compliance

Innovation in Practice

• Emphasizes the role of technology in early diagnosis, such as:
  • Genetic screening, flow cytometry, next-generation sequencing (NGS), and telemedicine consultations
• Contributed to the development of national protocols and clinical guidelines for managing rare pediatric hematological conditions

Consultation & Treatment Costs

Consultation Fee

• Initial Consultation Fee: Subject to variation based on clinical complexity, case history, and diagnostic needs.
• Follow-Up Consultations: May vary depending on frequency and additional assessments required.
• Teleconsultation options may also be available on request.

Customized Treatment Planning Dr. Rashmi Dalvi believes in formulating individualized treatment plans tailored to each child’s medical condition, age, and overall health status. The cost of treatment varies depending on:

• Diagnosis and disease severity
• Type and duration of therapy required
• Hospital infrastructure and support services
• Need for specialized diagnostics or multidisciplinary care

Role of Cancer Rounds

• Multidisciplinary cancer rounds play a key role in ensuring each treatment plan is:
  • Evidence-based, involving inputs from pediatric oncologists, hematologists, radiologists, pathologists, and supportive care teams
  • Continuously reviewed to adapt therapy based on response, side effects, and emerging needs
  • Holistic, addressing not only medical but also psychological, nutritional, and rehabilitative aspects

Estimated Treatment Cost Range (Indicative Only)

Treatment Modality	Estimated Cost Range (INR)
Initial Consultation + Basic Investigations	₹2,000 – ₹6,000
Chemotherapy (Per Cycle)	₹15,000 – ₹60,000
Blood Transfusion (Per Session)	₹4,000 – ₹10,000
Bone Marrow Aspiration & Biopsy	₹10,000 – ₹20,000
Management of Hemophilia (Factor Replacement)	₹8,000 – ₹30,000 (per session)
Immunodeficiency Workup & Therapy	₹20,000 – ₹80,000
Pediatric Leukemia Treatment (Full Course Estimate)	₹2.5 Lakhs – ₹8 Lakhs
Pediatric Lymphoma Treatment (Full Course Estimate)	₹2 Lakhs – ₹6 Lakhs
Supportive & Nutritional Care (Monthly Estimate)	₹5,000 – ₹15,000

Note: The above costs are approximate and may vary depending on the hospital infrastructure, treatment regimen, patient response, and use of newer agents or international protocols. Detailed estimates are provided after initial evaluation and case review. International Patient Support

• Languages Spoken: English, Hindi, Marathi
• Virtual Consultations: Available for national and international patients
• Assistance Services: Travel, visa, and accommodation support available via Cancer Rounds Team

Contact & Appointments For priority appointments, second opinions, or childhood disorder evaluations, contact the Cancer Rounds Team for a seamless and compassionate experience.